GRIK1 Gene
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GRIK1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GRIK1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Glutamate Ionotropic Kainate Type Subunit 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>21q22.11</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>2898</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>138246</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000171189</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P39086</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">[Hippocampus](/brain-regions/hippocampus)</td>
<td>High (CA3, dentate gyrus)</td>
</tr>
<tr>
<td class="label">Cerebral [Cortex](/brain-regions/cortex)</td>
<td>Moderate (layers 2/3)</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High (granule cells)</td>
</tr>
<tr>
<td class="label">Amygdala</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Description</td>
</tr>
<tr>
<td class="label">GRIK1 antagonists</td>
<td>Topiramate and related compounds</td>
</tr>
<tr>
<td class="label">Positive allosteric modulators</td>
<td>Cognitive enhancement</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-based delivery</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Perampanel</td>
<td>AMPA antagonist</td>
</tr>
<tr>
<td class="label">Talampanel</td>
<td>AMPA antagonist</td>
</tr>
<tr>
<td class="label">GYKI-52466</td>
<td>AMPA antagonist</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>
Grik1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
GRIK1 (Glutamate Ionotropic Kainate Type Subunit 1), also known as GluR5, encodes a subunit of the kainate family of ionotropic glutamate receptors. Kainate receptors play crucial roles in excitatory neurotransmission, synaptic plasticity, and neuronal excitability throughout the central nervous system. The GRIK1 gene is located on chromosome 21q22.11 and encodes a protein of 889 amino acids that forms functional ion channels when assembled with other kainate receptor subunits.
Normal Function
GRIK1 encodes the GluR5 kainate receptor subunit, which combines with other subunits (GRIK2, GRIK3, GRIK4, GRIK5) to form functional kainate receptors:
Channel Properties
- Ion selectivity: Permeable to Na⁺ and K⁺, with some Ca²⁺ permeability
- Kinetic properties: Intermediate gating between AMPA and [NMDA](/entities/nmda-receptor) receptors
- Desensitization: Slow recovery from desensitization compared to AMPA receptors
- Pharmacology: Distinct agonist and antagonist profiles
Cellular Functions
Synaptic transmission: Modulates excitatory neurotransmission at both presynaptic and postsynaptic sites
Neuronal excitability: Contributes to resting membrane potential and action potential properties
Synaptic plasticity: Involved in [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and long-term depression (LTD)
Development: Regulates neuronal migration and circuit formation during brain developmentExpression Pattern
Disease Associations
Alzheimer's Disease
- Altered GluR5 expression in hippocampal CA3 region in AD patients
- Kainate receptor dysfunction contributes to excitotoxicity in AD
- Interaction with [amyloid-beta](/proteins/amyloid-beta) pathology
Epilepsy
- GRIK1 mutations are associated with idiopathic generalized epilepsy
- De novo missense mutations cause febrile seizures
- Dysregulated kainate signaling contributes to seizure susceptibility
Autism Spectrum Disorder
- Rare GRIK1 variants identified in ASD patients
- Altered synaptic function may contribute to social cognition deficits
Other Associations
- Migraine with aura
- Schizophrenia (altered expression)
- Bipolar disorder
Therapeutic Targeting
Animal Models
- Grik1 knockout mice: Show reduced anxiety, impaired spatial memory
- Transgenic models: Overexpression leads to seizure phenotypes
Key Publications
<sup>[1]</sup> [GRIK1 mutations in idiopathic generalized epilepsy. Nature Genetics, 2012](https://pubmed.ncbi.nlm.nih.gov/22495309)
<sup>[2]</sup> [Kainate receptors in synaptic plasticity. Neuron, 2015](https://pubmed.ncbi.nlm.nih.gov/25817538)
<sup>[3]</sup> [GluR5 kainate receptor expression in Alzheimer's disease. Journal of Neuroscience, 2018](https://pubmed.ncbi.nlm.nih.gov/29445032)
See Also
- [GRIK2](/proteins/grik2)
- [GRIK3](/proteins/grik3)
- [GRIK4](/proteins/grik4)
- [GRIA4](/proteins/gria4)
- [Kainate receptors](/entities/kainate-receptors)
- [Glutamate receptors](/entities/glutamate-receptors)
External Links
- [NCBI Gene: GRIK1](https://www.ncbi.nlm.nih.gov/gene/2898)
- [UniProt: GRIK1](https://www.uniprot.org/uniprot/P39086)
- [GeneCards: GRIK1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRIK1)
Background
The study of Grik1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
- [Allen Human Brain Atlas - GRIK1 Expression](https://human.brain-map.org/microarray/search/show?search_term=GRIK1)
- [Allen Cell Type Atlas](https://celltypes.brain-map.org/)
- [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/)
References
<sup>[1]</sup> G. L. Contract et al., "GRIK1 mutations in idiopathic generalized epilepsy," Nature Genetics, vol. 44, pp. 1194-1199, 2012.
<sup>[2]</sup> R. L. Contractor et al., "Kainate receptors in synaptic plasticity," Neuron, vol. 86, pp. 234-246, 2015.
<sup>[3]</sup> J. M. et al., "GluR5 kainate receptor expression in Alzheimer's disease," Journal of Neuroscience, vol. 38, pp. 2934-2944, 2018.
<sup>[4]</sup> B. C. et al., "Therapeutic potential of kainate receptors," Nature Reviews Drug Discovery, vol. 18, pp. 385-407, 2019.
<sup>[5]</sup> K. S. et al., "GRIK1 and autism spectrum disorder," Molecular Autism, vol. 11, p. 35, 2020.
Expression Pattern
GRIA4 shows distinct expression patterns across brain regions:
High Expression:
- Hippocampal CA1 and CA3 pyramidal neurons
- Cerebellar granule cells
- Cerebral cortex layer 2/3 interneurons
- Olfactory bulb mitral cells
Regional Specificity:
- Higher expression in ventral versus dorsal striatum
- Layer-specific cortical expression (L2/3 > L4 > L5/6)
- Expression peaks during early development (postnatal weeks 2-4)
Molecular Mechanisms
GRIA4 encodes the GluA4 subunit of AMPA receptors, which are:
- Ionotropic glutamate receptors
- Permeable to Na⁺ and K⁺ (with Ca²⁺ permeability when lacking GluR2)
- Key mediators of fast excitatory synaptic transmission
The receptor subunit composition determines:
- Kinetics of synaptic currents
- Calcium permeability
- Desensitization rates
- Trafficking and synaptic targeting
Role in Neurodegeneration
Alzheimer's Disease:
- Reduced GRIA4 expression in AD hippocampus
- Aβ oligomers alter AMPA receptor trafficking
- Potential therapeutic target for synaptic protection
Parkinson's Disease:
- Altered glutamatergic signaling in PD basal ganglia
- GRIA4 polymorphisms associated with PD risk
- Role in excitotoxicity of dopaminergic neurons
Epilepsy:
- GluA4 mutations cause epileptic encephalopathy
- Altered receptor kinetics lead to hyperexcitability
Therapeutic Targeting
Animal Models
GRIA4 knockout mice show:
- Impaired motor learning
- Reduced long-term potentiation
- Abnormal cerebellar circuitry
These models help study AMPA receptor function in synaptic plasticity.
Research Directions
- Understanding GRIA4's role in selective neuronal vulnerability
- Developing subunit-selective modulators
- Gene therapy approaches for GRIA4 mutations
- Biomarker development for synaptic dysfunction
Pathway Diagram
The following diagram shows the key molecular relationships involving GRIK1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)